Cargando…
Association of Low Serum 25OHD Levels with Abnormal Bone Microarchitecture in Well-Differentiated Thyroid Cancer
The association of low levels of 25 hydroxyvitamin D (25OHD) with papillary thyroid cancer (PTC) is being studied, as to whether it is a risk factor or as a coincidental one. This study aimed to evaluate serum levels of deficiency, insufficiency, and sufficiency of 25OHD in PTC and its relationship...
Autores principales: | Hawkins Carranza, Federico, Guadalix Iglesias, Sonsoles, De Mingo Dominguez, María Luisa, Allo Miguel, Gonzalo, Arroba, Cristina Martín-Arriscado, Alvares, Begoña López, Martínez Diaz-Guerra, Guillermo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711525/ https://www.ncbi.nlm.nih.gov/pubmed/33271814 http://dx.doi.org/10.3390/medsci8040049 |
Ejemplares similares
-
Trabecular bone deterioration in differentiated thyroid cancer: Impact of long‐term TSH suppressive therapy
por: Hawkins Carranza, Federico, et al.
Publicado: (2020) -
Associations of Serum Total 25OHD, 25OHD3, and epi-25OHD3 with Insulin Resistance: Cross-Sectional Analysis of the National Health and Nutrition Examination Survey, 2011–2016
por: Zhou, Meiling, et al.
Publicado: (2022) -
Vitamin D (25OHD) Serum Seasonality in the United States
por: Kasahara, Amy K., et al.
Publicado: (2013) -
Calcifediol (25OHD) Deficiency and Its Treatment in Women’s Health and Fertility
por: Arnanz, Ana, et al.
Publicado: (2022) -
Data in support for the measurement of serum 25-hydroxyvitamin D (25OHD) by tandem mass spectrometry
por: Jensen, M.E., et al.
Publicado: (2016)